BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 1322233)

  • 21. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
    Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
    Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biology of Wilms' tumour.
    Pritchard-Jones K; Hawkins MM
    Lancet; 1997 Mar; 349(9053):663-4. PubMed ID: 9078193
    [No Abstract]   [Full Text] [Related]  

  • 23. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
    Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
    Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular biology of Wilms' tumor.
    Koo HP; Hensle TW
    Urol Clin North Am; 1993 May; 20(2):323-31. PubMed ID: 8388135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of Wilms' tumor: a blend of aberrant development and genomic imprinting.
    Junien C; Henry I
    Kidney Int; 1994 Nov; 46(5):1264-79. PubMed ID: 7853785
    [No Abstract]   [Full Text] [Related]  

  • 27. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells.
    Reeve AE; Sih SA; Raizis AM; Feinberg AP
    Mol Cell Biol; 1989 Apr; 9(4):1799-803. PubMed ID: 2542777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
    Kaneko Y; Takeda O; Homma C; Maseki N; Miyoshi H; Tsunematsu Y; Williams BG; Saunders GF; Sakurai M
    Jpn J Cancer Res; 1993 Jun; 84(6):616-24. PubMed ID: 8393432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
    Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
    Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymerase chain reaction-based risk assessment for Wilms tumor in sporadic aniridia.
    Gupta SK; De Becker I; Guernsey DL; Neumann PE
    Am J Ophthalmol; 1998 May; 125(5):687-92. PubMed ID: 9625553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Balanced reciprocal translocation (X;20) limited to Wilms' tumor in a Wiedemann-Beckwith syndrome.
    Diaz de Bustamante A; Delicado A; Garcia de Miguel P; Darnaude MT; de Torres ML; Zumel RM; Lopez Pajares I
    Cancer Genet Cytogenet; 1990 Mar; 45(1):35-9. PubMed ID: 2154323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
    Haber DA; Buckler AJ
    New Biol; 1992 Feb; 4(2):97-106. PubMed ID: 1313285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of chromosome 11p imbalances in aniridia and Wilms tumor patients.
    Busch M; Leube B; Thiel A; Schanze I; Beier M; Royer-Pokora B
    Am J Med Genet A; 2013 May; 161A(5):958-64. PubMed ID: 23494989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of linkage of familial Wilms' tumour to chromosomal band 11p13.
    Huff V; Compton DA; Chao LY; Strong LC; Geiser CF; Saunders GF
    Nature; 1988 Nov; 336(6197):377-8. PubMed ID: 2848200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours.
    Mannens M; Slater RM; Heyting C; Bliek J; de Kraker J; Coad N; de Pagter-Holthuizen P; Pearson PL
    Hum Genet; 1988 Dec; 81(1):41-8. PubMed ID: 2848758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A third Wilms' tumor locus on chromosome 16q.
    Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
    Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unbalanced translocation of chromosome 3p in Wilms' tumor.
    Walton JM; Lee CL; Mikhail E; Welch JP; Gillis DA
    J Pediatr Surg; 1992 Oct; 27(10):1311-4. PubMed ID: 1328583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetic basis of Wilms' tumour?
    Cole TR
    Br J Cancer; 1995 Feb; 71(2):427. PubMed ID: 7710515
    [No Abstract]   [Full Text] [Related]  

  • 40. Aniridia, gonadoblastoma, Wilms' tumor and deletion 11p13.
    Stefan H; Semecký V
    Acta Medica (Hradec Kralove); 1998; 41(1):29-33. PubMed ID: 9588071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.